title: The Ex-PRESS Glaucoma Filtration Device Implantation in Uveitic Glaucoma.
abstract: OBJECTIVE
  To evaluate the outcomes of the Ex-PRESS Filtration Device in patients with uveitic glaucoma.
  
  
  METHODS
  We reviewed 23 eyes, comparing control simple glaucoma patients (n = 11) to uveitic glaucoma patients (n = 12). Intraocular pressure (IOP) and glaucoma medications at the preoperative examination were compared with those at the 6-month and 10-14-month postoperative examination. Surgical success was defined as ≥25% decrease in intraocular pressure without hypotony, and/or decrease in glaucoma medications at 6 months follow-up.
  
  
  RESULTS
  Statistically significant reduction in mean IOP from preoperative levels occurred in both groups at 6 months follow-up (p<0.0001) and 10-14 months follow-up (p = 0.0007) and in the mean number of medications in the uveitic glaucoma (UG) group (p = 0.0313).
  
  
  CONCLUSIONS
  Surgical success was seen in 10 eyes in the control group (90.9%) and nine eyes (75%) in the UG group (p = 0.314). Ex-PRESS implantation is an effective surgical intervention for the management of uveitic glaucoma.
authors.affiliation: a Massachusetts Eye Research and Surgery Institution , Waltham , Massachusetts , USA.|b Ocular Immunology and Uveitis Foundation , Waltham , Massachusetts , USA.
authors.forename: Swetha
authors.initials: S
authors.lastname: Dhanireddy
authors.affiliation: a Massachusetts Eye Research and Surgery Institution , Waltham , Massachusetts , USA.|b Ocular Immunology and Uveitis Foundation , Waltham , Massachusetts , USA.|d Yale School of Medicine , New Haven , Connecticut , USA.
authors.forename: Ninani C
authors.initials: NC
authors.lastname: Kombo
authors.affiliation: a Massachusetts Eye Research and Surgery Institution , Waltham , Massachusetts , USA.|b Ocular Immunology and Uveitis Foundation , Waltham , Massachusetts , USA.
authors.forename: Abhishek R
authors.initials: AR
authors.lastname: Payal
authors.affiliation: a Massachusetts Eye Research and Surgery Institution , Waltham , Massachusetts , USA.|b Ocular Immunology and Uveitis Foundation , Waltham , Massachusetts , USA.|c Hospital de Olhos Santa Luzia, Recife , Pernambuco , Brazil.
authors.forename: Clovis Arcoverde
authors.initials: CA
authors.lastname: Freitas-Neto
authors.affiliation: a Massachusetts Eye Research and Surgery Institution , Waltham , Massachusetts , USA.|b Ocular Immunology and Uveitis Foundation , Waltham , Massachusetts , USA.
authors.forename: Janine
authors.initials: J
authors.lastname: Preble
authors.affiliation: a Massachusetts Eye Research and Surgery Institution , Waltham , Massachusetts , USA.|b Ocular Immunology and Uveitis Foundation , Waltham , Massachusetts , USA.|e Harvard Medical School , Boston , Massachusetts , USA.
authors.forename: C Stephen
authors.initials: CS
authors.lastname: Foster
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005901:Glaucoma / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D020327:Glaucoma Drainage Implants; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D008297:Male; D008875:Middle Aged; D019919:Prosthesis Implantation; D012189:Retrospective Studies; D014605:Uveitis / Q000150:complications*; D014792:Visual Acuity / Q000502:physiology
keywords: Ex-PRESS; glaucoma; glaucoma drainage device; surgical management; uveitic glaucoma; uveitis